Tag: Research
-
Sex May Influence Effectiveness of Common Heart Failure Drug
A novel heart failure drug called sacubitril-valsartan reduced the risk of hospitalizations for heart failure and death from cardiovascular causes more in women than in men, according to a study published in Circulation.
-
Centrioles Aid Cellular Migration
A new study has found cells with high numbers of centrioles more quickly migrated through layers of tissue, a process known as radial intercalation, which may provide new insights into the development of many cancers.
-
New Insights into Chromosome Folding
A new study has helped solve the mystery of how dysfunctional chromosome folding leads to cancer.
-
Elevated Gene Expression Linked to Poor Glioblastoma Survival
The elevated expression of a gene called LY6K was correlated with increased cancer cell growth and resistance to radiation therapy in glioblastoma, according to a recent Northwestern Medicine study.
-
COVID-19 Drug Trial Launches at Northwestern Medicine
Northwestern Medicine has enrolled its first participants in a new international clinical drug trial for COVID-19, testing remdesivir, a novel anti-viral drug developed to treat Ebola, and which has also shown antiviral activity in coronaviruses.
-
New Radiotherapy Method Reduces Cognitive Decline
A new method of delivering radiation during whole brain radiotherapy could reduce neurotoxicity without compromising effectiveness, according to a new study.
-
Northwestern Scientists Transform Lab for COVID-19 Testing
A special COVID-19 testing team has been put in place at Northwestern, with the goal of at least quadrupling the number of tests processed at Northwestern Medicine hospitals — from about 90 per day to more than 350 per day — and in the process, greatly reducing test result turnaround times.
-
Soulakis Joins IDPH to Fight COVID-19
Nicholas Soulakis, PhD, is taking a leave of absence from the medical school to work as an epidemiologist in the Illinois Department of Public Health Office of Policy, Planning and Statistics.
-
Drug Combination May Reduce Risk of Leukemia Relapse
Risk of relapse for chronic myeloid leukemia patients may be reduced through drug combination after discontinuing initial therapy, according to a Northwestern Medicine study published in the journal Leukemia.
-
‘Take this Seriously,’ Say Northwestern Doctors in COVID-19 Video
Using selfie video messages filmed in their workplaces, Northwestern Medicine physicians and medical experts on the front lines of the COVID-19 pandemic urge the community to take the health crisis seriously.
